Osaic Holdings’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
DTC
FCM
BBA
TCM
Osaic Holdings's IMVT Position: Q2 2026 in Review
Osaic Holdings increased its Immunovant (IMVT) stake by 37% in Q2 2026, buying an estimated $21.4K and bringing the position to 2,578 shares worth $99.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4949.
Osaic Holdings first reported a position in IMVT in Q3 2020 and has held it in 22 quarters since. The position peaked at $166K in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.
- Osaic Holdings held 2,578 shares of Immunovant worth $99.3K as of Q2 2026.
- Osaic Holdings bought 703 Immunovant shares in Q2 2026, an estimated $21.4K.
- Immunovant made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4949 holding.
- Osaic Holdings first reported a position in Immunovant in Q3 2020 and has held it in 22 quarters since.
- Osaic Holdings's Immunovant position peaked at $166K in Q4 2023.
- 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.